Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.
about
Marijuana: current concepts(†)Does Cannabidiol Protect Against Adverse Psychological Effects of THC?Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalizationEndocannabinoid signaling in social functioning: an RDoC perspectiveLevonantradol: asymmetric synthesis and structural analysisPlant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.Medical marijuana: more questions than answers.Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.Long-term CB₁ receptor blockade enhances vulnerability to anxiogenic-like effects of cannabinoidsRecent progress in neuroactive marine natural products.A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol.Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review.2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users.Cannabinoid modulation of midbrain urocortin 1 neurones during acute and chronic stress.The effects of cannabis use expectancies on self-initiated cannabis cessation.The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats.Disease-modifying effects of RHC80267 and JZL184 in a pilocarpine mouse model of temporal lobe epilepsy.Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice.
P2860
Q21090461-06AD56B5-CD1F-4FE8-870D-D286AD66B015Q21129107-BA757F42-06BD-4512-BFF6-54E6154C6BE8Q27009287-EE31CCA7-91BC-4490-972E-9EB2A027D9D1Q28067103-6EF2A304-931D-44A5-9E7E-68DB785CEECEQ28287893-6BAE692F-A8FB-46DA-902A-88604158D013Q34343456-617FE8DD-443B-4861-9031-8C5888D9709AQ34570676-C11FBCB8-90DC-46A4-83EA-4E702EDB3400Q35287466-CD6FC968-2F5A-4051-9F50-9E6356D912B2Q36950835-373ED618-37AE-4B2F-9109-998EB32E1BA5Q37639029-FA9F9262-A36B-4DE7-9265-6A130ABE9F56Q37662551-15E1EF89-80EF-4ACA-9E50-124CD4F9AC73Q39154540-491C1C24-8611-4135-90A8-03F3F5E27925Q39191943-4C54E97F-1222-4DF6-95D2-7A70436D5370Q39318898-E182B91F-45B0-411D-AAD4-7CEE406B76A5Q42508631-D344E825-ED85-4E09-9F58-F84A57A8A99FQ45327251-CE6A0925-6B3A-47EE-BE16-16B9F51D2707Q47591608-4900AA3A-659F-42B4-A768-D266D224943BQ47752617-FA8AB68D-C638-4A45-8FBB-95CBC33F2D6BQ50982694-1F73DF0C-3DAA-4070-B82C-5758CE266580
P2860
Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cannabinoid-related agents in ...... ledge and future perspectives.
@en
type
label
Cannabinoid-related agents in ...... ledge and future perspectives.
@en
prefLabel
Cannabinoid-related agents in ...... ledge and future perspectives.
@en
P2860
P1476
Cannabinoid-related agents in ...... wledge and future perspectives
@en
P2093
Simone Tambaro
P2860
P356
10.2174/157488912798842269
P577
2012-04-01T00:00:00Z